Mr. Shen et al., IDENTIFICATION OF ADENOSINE RECEPTORS IN HUMAN SPERMATOZOA, Clinical and experimental pharmacology and physiology, 20(7-8), 1993, pp. 527-534
1. The effects of adenosine receptor agonists and antagonists on human
sperm motility have been studied. Specific binding sites for adenosin
e and its analogues on human sperm were also investigated. 2. Agonists
stimulated human sperm motility in a dose-dependent manner with a pot
ency order of 5'-N-ethylcarboxamidoadenosine (NECA, EC50 = 0.3 mumol/L
) >2-[p-(carboxyethyl) phenylethylamino]-5'-N-ethylcarboxamidoadenosin
e (CGS-21680, EC50 = 10 mumol/L) > adenosine (EC50 = 100 mumol/ L). 3.
NECA-stimulated motility was competitively inhibited by various adeno
sine receptor antagonists. The potency order was 3,7-dimethy-1-proparg
ylxanthine>8-(p-sulfophenyl) theophylline>xanthine amino congener. 4.
The radioligand [H-3]-NECA bound to sperm membrane in a saturable mann
er with a B(max) of 21.3 pmol/mg protein and equilibrium K(d) of 4 mum
ol/L. Adenosine agonists and antagonists competed for [H-3]-NECA bindi
ng with the same rank order of potency as for the stimulation of human
sperm motility. 5. GTP-gammas inhibited 63% of specific [H-3]-NECA bi
nding with IC50 value of 11 nmol/L. This suggests that the [H-3]-NECA
binding sites may be coupled to one or more G proteins. 6. These resul
ts indicate the presence of adenosine A2 receptors on human sperm whic
h are responsible for adenosine-mediated enhancement of sperm motility
.